Potent agonist action of 2-thioether derivatives of adenine nucleotides at adenylyl cyclase-linked P2Y-purinoceptors

British Journal of Pharmacology
J L BoyerT K Harden

Abstract

1. Analogues of adenine nucleotides inhibited beta-adrenoceptor-stimulated cyclic AMP accumulation in C6 rat glioma cells with a pharmacological selectivity consistent with that for involvement of a P2Y-purinoceptor. 2. The inhibitory effect of adenine nucleotides was completely prevented by pretreatment of cells with pertussis toxin. 3. The capacity of a series of recently synthesized 2-thioether analogues of adenine nucleotides to inhibit cyclic AMP accumulation was examined. Several ATP analogues, e.g. 2-cyclohexylthio and 2-hexylthio ATP, inhibited cyclic AMP accumulation with EC50 values of approximately 30 pM. These values represent 100,000 fold increases in potency over ATP. 4. Analogues of ADP exhibited the same remarkable increase in potency relative to their natural congener and diphosphates were at least as potent as the corresponding triphosphates at the C6 cell P2Y-purinoceptor. 5. The relative potencies of a broad series of agonists at the C6 cell receptor did not correspond to the relative potencies of the same compounds for activation of P2Y-purinoceptors on turkey erythrocyte membranes. Some agonists, particularly 2-thioether derivatives were more potent for stimulation of the C6 cell receptor, whereas other ag...Continue Reading

References

Jan 1, 1990·Annual Review of Pharmacology and Toxicology·E C HulmeN J Buckley
Sep 15, 1989·Biochemical and Biophysical Research Communications·I PianetJ Labouesse
Jan 1, 1985·General Pharmacology·G Burnstock, C Kennedy
Jun 15, 1980·The Biochemical Journal·S Cockcroft, B D Gomperts
Jan 1, 1995·Annual Review of Pharmacology and Toxicology·T K HardenR A Nicholas
Jun 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·K D LustigD Julius
Sep 1, 1993·The American Journal of Physiology·G R Dubyak, C el-Moatassim

❮ Previous
Next ❯

Citations

Apr 13, 2011·Purinergic Signalling·Kenneth A JacobsonStefano Costanzi
Nov 7, 2000·Neuroscience Letters·K Sak
Dec 24, 1997·British Journal of Pharmacology·J B SchachterT K Harden
Jun 18, 1998·British Journal of Pharmacology·M S FaguraP Leff
May 1, 1996·British Journal of Pharmacology·J B SchachterT K Harden
Aug 6, 2005·Neurochemistry International·Katrin Sak, Peter Illes
Nov 2, 2020·Biochemical Pharmacology·Kenneth A JacobsonChrista E Müller

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.